DESORIO-E3
Desogestrel BP0.15mg & Ethinylestradiol IP 0.03 mg Tablets
Product Technical Snapshot
Official pharmaceutical registration and manufacturing parameters
| Brand Name | DESORIO-E3 |
| Active Formulation (Salt) | Desogestrel BP0.15mg & Ethinylestradiol IP 0.03 mg Tablets |
| Dosage Form | TABLETS |
| Packaging Presentation | 10 x 1 x 21Blister |
| Therapeutic Category | TABLETS |
| Regulatory Classification | Schedule H Prescription Drug |
| Pharmacopoeial Standard | IP / BP / USP Pharmacopoeial Standards |
| Quality Certifications | WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility |
| Marketed & Distributed By | Riomedica Healthcare Pvt. Ltd. (Ambala Cantt & Panchkula, Haryana) |
| B2B Franchise Availability | Monopoly PCD Franchise rights available across all Indian districts |
What is DESORIO-E3?
Therapeutic monograph and clinical profile
DESORIO-E3 (Desogestrel BP0.15mg & Ethinylestradiol IP 0.03 mg Tablets) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 10 x 1 x 21Blister, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Contraception / Regulation of Menstrual Cycles.
Key Formulation Highlights
Why healthcare professionals recommend DESORIO-E3
Therapeutic Uses & Clinical Indications
Conditions and clinical disorders managed by this medicine
Recommended Clinical Indications:
Contraception / Regulation of Menstrual Cycles
Pharmacological Mechanism of Action
How DESORIO-E3 acts biochemically in the body
Delivers targeted active therapeutic release with rapid absorption and high safety profile.
Dosage & Administration Guidance
Proper usage directions under clinical supervision
As directed by the physician or healthcare professional. Take with water at prescribed intervals.
Precautions, Warnings & Contraindications
Safety guidelines and patient health considerations
Clinical Safety & Medical Advice:
Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.
Possible Side Effects
Tolerability profile and reporting
Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.
Storage & Handling Instructions
Maintaining formulation stability and shelf-life
Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.
Exclusive PCD Pharma Franchise Opportunity for DESORIO-E3
Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for DESORIO-E3 across India with comprehensive visual aids, prompt dispatch, and high profit margins.
Frequently Asked Questions (FAQs)
Common queries regarding DESORIO-E3
What is DESORIO-E3 used for?
What is the printed packaging and MRP of DESORIO-E3?
How can I get monopoly PCD franchise for DESORIO-E3?
Related Formulations in TABLETS
Explore complementary WHO-GMP certified healthcare formulations
